{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T12:43:17Z","timestamp":1777725797434,"version":"3.51.4"},"reference-count":68,"publisher":"IMR Press","issue":"2","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Swiss Federal Office of Public Health","award":["470 00.000142"],"award-info":[{"award-number":["470 00.000142"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Alpha Psychiatry"],"abstract":"<jats:p>Background: Severe opioid dependence is associated with neurocognitive impairments, potentially aggravated by recurrent overdose-induced hypoxia and long-term opioid use\u2013induced hypoperfusion. Although hypoxia-related impairments seem to vary with severity, duration, and frequency, findings are inconsistent. Moreover, evidence specific to opioid-related hypoxia is scarce. Given this gap, this prospective pilot study examined whether hypoxic incidents predict poorer neurocognitive performance and reduced improvement during three months of opioid agonist treatment. Methods: Forty-seven individuals with opioid dependence (mean age = 34.3 years; 27.7% female) completed a neuropsychological assessment that included 12 validated tests covering a broad range of neurocognitive domains at baseline and at study end (n = 33; 33% female). Results: The repeated-measures ANOVA yielded no significant effects of Time, Group (hypoxic incidents vs. no hypoxic incidents), or their interaction on neurocognitive performance in the domains of attention, memory, or executive functions. This suggests that changes in neurocognitive performance over time did not differ significantly between participants with and without a history of hypoxic incidents. However, post-hoc analyses indicated that hypoxic incidents requiring resuscitation may adversely affect neurocognitive functioning. Conclusions: These findings suggest that hypoxic incidents without resuscitation may not aggravate long-term neurocognitive impairments, supporting previous findings that brain cells can tolerate transient hypoxia. These results may also suggest that treatment planning should prioritize history of resuscitation incidents along with other prognostic factors such as duration of opioid use, baseline neurocognitive impairments, co-occurring mental health conditions, and socioeconomic factors. Future studies with larger samples and more precise assessments of hypoxia are essential to further clarify these findings and optimize treatment approaches.<\/jats:p>","DOI":"10.31083\/ap45138","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:41:17Z","timestamp":1777459277000},"source":"Crossref","is-referenced-by-count":0,"title":["Effect of Overdose-Induced Hypoxia on Neurocognitive Performance in Individuals With Opioid Dependence: A Prospective Multicenter Study"],"prefix":"10.31083","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6688-7252","authenticated-orcid":true,"given":"Sunsha","family":"Chamakalayil","sequence":"first","affiliation":[{"name":"Division of Substance Use Disorders, Psychiatric University Clinics Basel, 4002 Basel, Switzerland"},{"name":"Faculty of Medicine, University of Basel, 4056 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2175-2765","authenticated-orcid":true,"given":"Serge","family":"Brand","sequence":"additional","affiliation":[{"name":"Division of Sport and Psychosocial Health, Department of Sport, Exercise, and Health, University of Basel, 4052 Basel, Switzerland"},{"name":"Center for Affective, Stress and Sleep Disorders; Center for Disaster Psychiatry and Disaster Psychology, Psychiatric University Clinics Basel (UPK), 4002 Basel, Switzerland"},{"name":"Substance Abuse Prevention Research Center, Sleep Disorders Research Center, Kermanshah University of Medical Sciences (KUMS), 67198-51451 Kermanshah, Iran"},{"name":"School of Medicine, Tehran University of Medical Sciences (TUMS), 14167-53955 Tehran, Iran"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3088-0331","authenticated-orcid":true,"given":"Marc","family":"Vogel","sequence":"additional","affiliation":[{"name":"Division of Substance Use Disorders, Psychiatric University Clinics Basel, 4002 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6140-8948","authenticated-orcid":true,"given":"Markus","family":"Gerber","sequence":"additional","affiliation":[{"name":"Division of Sport and Psychosocial Health, Department of Sport, Exercise, and Health, University of Basel, 4052 Basel, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1552-5822","authenticated-orcid":true,"given":"Kenneth M.","family":"D\u00fcrsteler","sequence":"additional","affiliation":[{"name":"Division of Substance Use Disorders, Psychiatric University Clinics Basel, 4002 Basel, Switzerland"},{"name":"Centre for Addictive Disorders, Department for Psychiatry, Psychotherapy and Psychosomatics, University Hospital of Psychiatry Zurich, 8001 Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2026,4,8]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","unstructured":"Chalhoub RM, Kalivas PW. Non-Opioid Treatments for Opioid Use Disorder: Rationales and Data to Date. Drugs. 2020; 80: 1509\u20131524.","DOI":"10.1007\/s40265-020-01373-1"},{"key":"ref2","doi-asserted-by":"publisher","unstructured":"Pandria N, Kovatsi L, Vivas AB, Bamidis PD. Resting-state Abnormalities in Heroin-dependent Individuals. Neuroscience. 2018; 378: 113\u2013145.","DOI":"10.1016\/j.neuroscience.2016.11.018"},{"key":"ref3","doi-asserted-by":"publisher","unstructured":"Li W, Li Q, Zhu J, Qin Y, Zheng Y, Chang H, et al. White matter impairment in chronic heroin dependence: a quantitative DTI study. Brain Research. 2013; 1531: 58\u201364.","DOI":"10.1016\/j.brainres.2013.07.036"},{"key":"ref4","doi-asserted-by":"publisher","unstructured":"Qiu Y, Jiang G, Su H, Lv X, Zhang X, Tian J, et al. Progressive white matter microstructure damage in male chronic heroin dependent individuals: a DTI and TBSS study. PLoS ONE. 2013; 8: e63212.","DOI":"10.1371\/journal.pone.0063212"},{"key":"ref5","doi-asserted-by":"publisher","unstructured":"Wollman SC, Alhassoon OM, Stern MJ, Hall MG, Rompogren J, Kimmel CL, et al. White matter abnormalities in long-term heroin users: a preliminary neuroimaging meta-analysis. The American Journal of Drug and Alcohol Abuse. 2015; 41: 133\u2013138.","DOI":"10.3109\/00952990.2014.985829"},{"key":"ref6","doi-asserted-by":"publisher","unstructured":"Wollman SC, Hauson AO, Hall MG, Connors EJ, Allen KE, Stern MJ, et al. Neuropsychological functioning in opioid use disorder: A research synthesis and meta-analysis. The American Journal of Drug and Alcohol Abuse. 2019; 45: 11\u201325.","DOI":"10.1080\/00952990.2018.1517262"},{"key":"ref7","doi-asserted-by":"publisher","unstructured":"Baldacchino A, Armanyous M, Balfour DJK, Humphris G, Matthews K. Neuropsychological functioning and chronic methadone use: A systematic review and meta-analysis. Neuroscience and Biobehavioral Reviews. 2017; 73: 23\u201338.","DOI":"10.1016\/j.neubiorev.2016.11.008"},{"key":"ref8","doi-asserted-by":"publisher","unstructured":"Baldacchino A, Balfour DJK, Passetti F, Humphris G, Matthews K. Neuropsychological consequences of chronic opioid use: a quantitative review and meta-analysis. Neuroscience and Biobehavioral Reviews. 2012; 36: 2056\u20132068.","DOI":"10.1016\/j.neubiorev.2012.06.006"},{"key":"ref9","doi-asserted-by":"publisher","unstructured":"Bach P, Frischknecht U, Reinhard I, Bekier N, Demirakca T, Ende G, et al. Impaired working memory performance in opioid-dependent patients is related to reduced insula gray matter volume: a voxel-based morphometric study. European Archives of Psychiatry and Clinical Neuroscience. 2021; 271: 813\u2013822.","DOI":"10.1007\/s00406-019-01052-7"},{"key":"ref10","doi-asserted-by":"publisher","unstructured":"Fareed A, Kim J, Ketchen B, Kwak WJ, Wang D, Shongo-Hiango H, et al. Effect of heroin use on changes of brain functions as measured by functional magnetic resonance imaging, a systematic review. Journal of Addictive Diseases. 2017; 36: 105\u2013116.","DOI":"10.1080\/10550887.2017.1280898"},{"key":"ref11","doi-asserted-by":"publisher","unstructured":"Darke S, Sims J, McDonald S, Wickes W. Cognitive impairment among methadone maintenance patients. Addiction (Abingdon, England). 2000; 95: 687\u2013695.","DOI":"10.1046\/j.1360-0443.2000.9556874.x"},{"key":"ref12","doi-asserted-by":"publisher","unstructured":"Schmidt P, Haberth\u00fcr A, Soyka M. Cognitive Functioning in Formerly Opioid-Dependent Adults after At Least 1 Year of Abstinence: A Naturalistic Study. European Addiction Research. 2017; 23: 269\u2013275.","DOI":"10.1159\/000485032"},{"key":"ref13","doi-asserted-by":"publisher","unstructured":"Mindt MR, Coulehan K, Aghvinian M, Scott TM, Olsen JP, Cunningham CO, et al. Underrepresentation of diverse populations and clinical characterization in opioid agonist treatment research: A systematic review of the neurocognitive effects of buprenorphine and methadone treatment. Journal of Substance Abuse Treatment. 2022; 135: 108644.","DOI":"10.1016\/j.jsat.2021.108644"},{"key":"ref14","doi-asserted-by":"publisher","unstructured":"Ersche KD, Clark L, London M, Robbins TW, Sahakian BJ. Profile of executive and memory function associated with amphetamine and opiate dependence. Neuropsychopharmacology: Official Publication of the American College of Neuropsychopharmacology. 2006; 31: 1036\u20131047.","DOI":"10.1038\/sj.npp.1300889"},{"key":"ref15","unstructured":"Mitrovi\u0107 SM, Dickov A, Vu\u010dkovi\u0107 N, Mitrovi\u0107 D, Budi\u0161a D. The effect of heroin on verbal memory. Psychiatria Danubina. 2011; 23: 53\u201359."},{"key":"ref16","doi-asserted-by":"publisher","unstructured":"Prosser J, London ED, Galynker II. Sustained attention in patients receiving and abstinent following methadone maintenance treatment for opiate dependence: performance and neuroimaging results. Drug and Alcohol Dependence. 2009; 104: 228\u2013240.","DOI":"10.1016\/j.drugalcdep.2009.04.022"},{"key":"ref17","doi-asserted-by":"publisher","unstructured":"Pirastu R, Fais R, Messina M, Bini V, Spiga S, Falconieri D, et al. Impaired decision-making in opiate-dependent subjects: effect of pharmacological therapies. Drug and Alcohol Dependence. 2006; 83: 163\u2013168.","DOI":"10.1016\/j.drugalcdep.2005.11.008"},{"key":"ref18","doi-asserted-by":"publisher","unstructured":"Soyka M, Lieb M, Kagerer S, Zingg C, Koller G, Lehnert P, et al. Cognitive functioning during methadone and buprenorphine treatment: results of a randomized clinical trial. Journal of Clinical Psychopharmacology. 2008; 28: 699\u2013703.","DOI":"10.1097\/JCP.0b013e31818a6d38"},{"key":"ref19","doi-asserted-by":"publisher","unstructured":"Bernhardt N, Petzold J, Gro\u00df C, Scheck A, Pooseh S, Mayer-Pelinski R, et al. Neurocognitive Dysfunctions and Their Therapeutic Modulation in Patients With Methamphetamine Dependence: A Pilot Study. Frontiers in Psychiatry. 2020; 11: 581.","DOI":"10.3389\/fpsyt.2020.00581"},{"key":"ref20","doi-asserted-by":"publisher","unstructured":"Bates ME, Voelbel GT, Buckman JF, Labouvie EW, Barry D. Short-term neuropsychological recovery in clients with substance use disorders. Alcoholism, Clinical and Experimental Research. 2005; 29: 367\u2013377.","DOI":"10.1097\/01.alc.0000156131.88125.2a"},{"key":"ref21","doi-asserted-by":"publisher","unstructured":"Gruber SA, Tzilos GK, Silveri MM, Pollack M, Renshaw PF, Kaufman MJ, et al. Methadone maintenance improves cognitive performance after two months of treatment. Experimental and Clinical Psychopharmacology. 2006; 14: 157\u2013164.","DOI":"10.1037\/1064-1297.14.2.157"},{"key":"ref22","doi-asserted-by":"publisher","unstructured":"Ghosh A, Mahintamani T, Rana DK, Basu D, Mattoo SK. Six-month buprenorphine-naloxone treatment is associated with neurocognitive function improvement in opioid dependence. Indian Journal of Psychiatry. 2022; 64: 199\u2013208.","DOI":"10.4103\/indianjpsychiatry.indianjpsychiatry_792_21"},{"key":"ref23","doi-asserted-by":"publisher","unstructured":"Bateman JT, Saunders SE, Levitt ES. Understanding and countering opioid-induced respiratory depression. British Journal of Pharmacology. 2023; 180: 813\u2013828.","DOI":"10.1111\/bph.15580"},{"key":"ref24","doi-asserted-by":"publisher","unstructured":"Kiyatkin EA. Respiratory depression and brain hypoxia induced by opioid drugs: Morphine, oxycodone, heroin, and fentanyl. Neuropharmacology. 2019; 151: 219\u2013226.","DOI":"10.1016\/j.neuropharm.2019.02.008"},{"key":"ref25","doi-asserted-by":"publisher","unstructured":"Solis E, Jr, Cameron-Burr KT, Kiyatkin EA. Heroin Contaminated with Fentanyl Dramatically Enhances Brain Hypoxia and Induces Brain Hypothermia. eNeuro. 2017; 4: ENEURO.0323-17.2017.","DOI":"10.1523\/ENEURO.0323-17.2017"},{"key":"ref26","doi-asserted-by":"publisher","unstructured":"Cadet JL, Bisagno V, Milroy CM. Neuropathology of substance use disorders. Acta Neuropathologica. 2014; 127: 91\u2013107.","DOI":"10.1007\/s00401-013-1221-7"},{"key":"ref27","doi-asserted-by":"publisher","unstructured":"Winstanley EL, Mahoney JJ, 3rd, Castillo F, Comer SD. Neurocognitive impairments and brain abnormalities resulting from opioid-related overdoses: A systematic review. Drug and Alcohol Dependence. 2021; 226: 108838.","DOI":"10.1016\/j.drugalcdep.2021.108838"},{"key":"ref28","doi-asserted-by":"publisher","unstructured":"D\u00fcrsteler-Mac Farland KM, St\u00f6rmer R, Seifritz E, Hug I, M\u00fcller-Spahn F, Ladewig D, et al. Opioid-associated effects on oxygen saturation. Addiction (Abingdon, England). 2000; 95: 285\u2013287.","DOI":"10.1080\/09652140031955"},{"key":"ref29","doi-asserted-by":"publisher","unstructured":"Stohler R, D\u00fcrsteler KM, St\u00f6rmer R, Seifritz E, Hug I, Sattler-Mayr J, et al. Rapid cortical hemoglobin deoxygenation after heroin and methadone injection in humans: a preliminary report. Drug and Alcohol Dependence. 1999; 57: 23\u201328.","DOI":"10.1016\/s0376-8716(99)00036-8"},{"key":"ref30","doi-asserted-by":"publisher","unstructured":"Stoermer R, Drewe J, Dursteler-Mac Farland KM, Hock C, Mueller-Spahn F, Ladewig D, et al. Safety of injectable opioid maintenance treatment for heroin dependence. Biological Psychiatry. 2003; 54: 854\u2013861.","DOI":"10.1016\/s0006-3223(03)00290-7"},{"key":"ref31","doi-asserted-by":"publisher","unstructured":"Haselhorst R, D\u00fcrsteler-MacFarland KM, Scheffler K, Ladewig D, M\u00fcller-Spahn F, Stohler R, et al. Frontocortical N-acetylaspartate reduction associated with long-term i.v. heroin use. Neurology. 2002; 58: 305\u2013307.","DOI":"10.1212\/wnl.58.2.305"},{"key":"ref32","doi-asserted-by":"publisher","unstructured":"Degenhardt L, Grebely J, Stone J, Hickman M, Vickerman P, Marshall BDL, et al. Global patterns of opioid use and dependence: harms to populations, interventions, and future action. Lancet (London, England). 2019; 394: 1560\u20131579.","DOI":"10.1016\/S0140-6736(19)32229-9"},{"key":"ref33","doi-asserted-by":"publisher","unstructured":"Denier N, Schmidt A, Gerber H, Schmid O, Riecher-R\u00f6ssler A, Wiesbeck GA, et al. Association of frontal gray matter volume and cerebral perfusion in heroin addiction: a multimodal neuroimaging study. Frontiers in Psychiatry. 2013; 4: 135.","DOI":"10.3389\/fpsyt.2013.00135"},{"key":"ref34","doi-asserted-by":"publisher","unstructured":"Wollman SC, Alhassoon OM, Hall MG, Stern MJ, Connors EJ, Kimmel CL, et al. Gray matter abnormalities in opioid-dependent patients: A neuroimaging meta-analysis. The American Journal of Drug and Alcohol Abuse. 2017; 43: 505\u2013517.","DOI":"10.1080\/00952990.2016.1245312"},{"key":"ref35","doi-asserted-by":"publisher","unstructured":"King F, Morris NA, Schmahmann JD. Delayed Posthypoxic Leukoencephalopathy: Improvement with Antioxidant Therapy. Case Reports in Neurology. 2015; 7: 242\u2013246.","DOI":"10.1159\/000441892"},{"key":"ref36","doi-asserted-by":"publisher","unstructured":"Betts AM, Ritter JL, Kubal WS. Reversible delayed posthypoxic leukoencephalopathy after drug overdose: MRI findings in a collection of patients. Emergency Radiology. 2012; 19: 165\u2013173.","DOI":"10.1007\/s10140-011-1013-0"},{"key":"ref37","doi-asserted-by":"publisher","unstructured":"Zamora CA, Nauen D, Hynecek R, Ilica AT, Izbudak I, Sair HI, et al. Delayed posthypoxic leukoencephalopathy: a case series and review of the literature. Brain and Behavior. 2015; 5: e00364.","DOI":"10.1002\/brb3.364"},{"key":"ref38","doi-asserted-by":"publisher","unstructured":"Anderson CA, Arciniegas DB. Cognitive sequelae of hypoxic-ischemic brain injury: a review. NeuroRehabilitation. 2010; 26: 47\u201363.","DOI":"10.3233\/NRE-2010-0535"},{"key":"ref39","doi-asserted-by":"publisher","unstructured":"Caine D, Watson JD. Neuropsychological and neuropathological sequelae of cerebral anoxia: a critical review. Journal of the International Neuropsychological Society: JINS. 2000; 6: 86\u201399.","DOI":"10.1017\/s1355617700611116"},{"key":"ref40","doi-asserted-by":"publisher","unstructured":"Todaro DR, Li X, Pereira-Rufino LS, Manza P, Nasrallah IM, Das S, et al. Hippocampal volume loss in individuals with a history of non-fatal opioid overdose. Addiction Biology. 2023; 28: e13336.","DOI":"10.1111\/adb.13336"},{"key":"ref41","doi-asserted-by":"publisher","unstructured":"Brownlee NNM, Wilson FC, Curran DB, Lyttle N, McCann JP. Neurocognitive outcomes in adults following cerebral hypoxia: A systematic literature review. NeuroRehabilitation. 2020; 47: 83\u201397.","DOI":"10.3233\/NRE-203135"},{"key":"ref42","unstructured":"Zibbell J, Howard J, Clarke SD, Ferrell A, Karon S. Non-fatal opioid overdose and associated health outcomes: Final summary report. US Department of Health and Human Services. 2019; 33: 1\u201323."},{"key":"ref43","doi-asserted-by":"publisher","unstructured":"Huisa BN, Gasparovic C, Taheri S, Prestopnik JL, Rosenberg GA. Imaging of subacute blood-brain barrier disruption after methadone overdose. Journal of Neuroimaging: Official Journal of the American Society of Neuroimaging. 2013; 23: 441\u2013444.","DOI":"10.1111\/j.1552-6569.2011.00669.x"},{"key":"ref44","doi-asserted-by":"publisher","unstructured":"Salgado RA, Jorens PG, Baar I, Cras P, Hans G, Parizel PM. Methadone-induced toxic leukoencephalopathy: MR imaging and MR proton spectroscopy findings. AJNR. American Journal of Neuroradiology. 2010; 31: 565\u2013566.","DOI":"10.3174\/ajnr.A1889"},{"key":"ref45","doi-asserted-by":"publisher","unstructured":"Greer DM. Mechanisms of injury in hypoxic-ischemic encephalopathy: implications to therapy. Seminars in Neurology. 2006; 26: 373\u2013379.","DOI":"10.1055\/s-2006-948317"},{"key":"ref46","doi-asserted-by":"publisher","unstructured":"Beeskow AB, Oberstadt M, Saur D, Hoffmann KT, Lobsien D. Delayed Post-hypoxic Leukoencephalopathy (DPHL)-An Uncommon Variant of Hypoxic Brain Damage in Adults. Frontiers in Neurology. 2018; 9: 708.","DOI":"10.3389\/fneur.2018.00708"},{"key":"ref47","doi-asserted-by":"publisher","unstructured":"Darke S, Williamson A, Ross J, Mills KL, Havard A, Teesson M. Patterns of nonfatal heroin overdose over a 3-year period: findings from the Australian treatment outcome study. Journal of Urban Health: Bulletin of the New York Academy of Medicine. 2007; 84: 283\u2013291.","DOI":"10.1007\/s11524-006-9156-0"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Levy DE, Caronna JJ, Singer BH, Lapinski RH, Frydman H, Plum F. Predicting outcome from hypoxic-ischemic coma. JAMA. 1985; 253: 1420\u20131426.","DOI":"10.1001\/jama.1985.03350340072020"},{"key":"ref49","doi-asserted-by":"publisher","unstructured":"Alexander MP, Lafleche G, Schnyer D, Lim C, Verfaellie M. Cognitive and functional outcome after out of hospital cardiac arrest. Journal of the International Neuropsychological Society: JINS. 2011; 17: 364\u2013368.","DOI":"10.1017\/S1355617710001633"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"First M. Structured Clinical Interview for the DSM (SCID). The Encyclopedia of Clinical Psychology (pp. 1\u20136). John Wiley & Sons, Ltd: USA. 2015.","DOI":"10.1002\/9781118625392.wbecp351"},{"key":"ref51","unstructured":"Gsellhofer B, K\u00fcfner H, Vogt M, Weiler D. European Addiction Severity Index: Manual f\u00fcr Training und Durchf\u00fchrung. Schneider Verlag Hohengehren GmbH: Baltmannsweiler. 1999."},{"key":"ref52","doi-asserted-by":"publisher","unstructured":"McLellan AT, Kushner H, Metzger D, Peters R, Smith I, Grissom G, et al. The Fifth Edition of the Addiction Severity Index. Journal of Substance Abuse Treatment. 1992; 9: 199\u2013213.","DOI":"10.1016\/0740-5472(92)90062-s"},{"key":"ref53","unstructured":"Lezak MD, Howieson DB, Loring DW, Fischer JS. Neuropsychological assessment. Oxford University Press, USA: 2004."},{"key":"ref54","unstructured":"Regard M, Landis T, Casey J, Maggiorini M, B\u00e4rtsch P, Oelz O. Cognitive changes at high altitude in healthy climbers and in climbers developing acute mountain sickness. Aviation, Space, and Environmental Medicine. 1991; 62: 291\u2013295."},{"key":"ref55","doi-asserted-by":"publisher","unstructured":"Regard M, Oelz O, Brugger P, Landis T. Persistent cognitive impairment in climbers after repeated exposure to extreme altitude. Neurology. 1989; 39: 210\u2013213.","DOI":"10.1212\/wnl.39.2.210"},{"key":"ref56","doi-asserted-by":"publisher","unstructured":"Griva K, Stygall J, Wilson MH, Martin D, Levett D, Mitchell K, et al. Caudwell Xtreme Everest: A prospective study of the effects of environmental hypoxia on cognitive functioning. PloS One. 2017; 12: e0174277.","DOI":"10.1371\/journal.pone.0174277"},{"key":"ref57","unstructured":"Stohler R, Hug I, Knoll B, Mohler B, Ladewig D. Initial results with withdrawal treatments of male and female participants in the diversified Janus opiate prescription project in Basel. Praxis. 1996; 85: 1537\u20131541."},{"key":"ref58","doi-asserted-by":"publisher","unstructured":"Chamakalayil S, Stohler R, Moldovanyi A, Gerber M, Brand S, D\u00fcrsteler KM. Neurocognitive performance of patients undergoing intravenous versus oral opioid agonist treatment: a prospective multicenter study on three-month treatment effects. Frontiers in Psychiatry. 2024; 15: 1375895.","DOI":"10.3389\/fpsyt.2024.1375895"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"Hossmann KA. The hypoxic brain. Insights from ischemia research. Advances in Experimental Medicine and Biology. 1999; 474: 155\u2013169.","DOI":"10.1007\/978-1-4615-4711-2_14"},{"key":"ref60","doi-asserted-by":"publisher","unstructured":"Damgaard V, Mariegaard J, Lindhardsen JM, Ehrenreich H, Miskowiak KW. Neuroprotective Effects of Moderate Hypoxia: A Systematic Review. Brain Sciences. 2023; 13: 1648.","DOI":"10.3390\/brainsci13121648"},{"key":"ref61","doi-asserted-by":"publisher","unstructured":"Choi YK. Detrimental Roles of Hypoxia-Inducible Factor-1\u03b1 in Severe Hypoxic Brain Diseases. International Journal of Molecular Sciences. 2024; 25: 4465.","DOI":"10.3390\/ijms25084465"},{"key":"ref62","doi-asserted-by":"publisher","unstructured":"Neves D, Salazar IL, Almeida RD, Silva RM. Molecular mechanisms of ischemia and glutamate excitotoxicity. Life Sciences. 2023; 328: 121814.","DOI":"10.1016\/j.lfs.2023.121814"},{"key":"ref63","doi-asserted-by":"publisher","unstructured":"Wang X, Cui L, Ji X. Cognitive impairment caused by hypoxia: from clinical evidences to molecular mechanisms. Metabolic Brain Disease. 2022; 37: 51\u201366.","DOI":"10.1007\/s11011-021-00796-3"},{"key":"ref64","doi-asserted-by":"publisher","unstructured":"Laitio R, Hynninen M, Arola O, Virtanen S, Parkkola R, Saunavaara J, et al. Effect of Inhaled Xenon on Cerebral White Matter Damage in Comatose Survivors of Out-of-Hospital Cardiac Arrest: A Randomized Clinical Trial. JAMA. 2016; 315: 1120\u20131128.","DOI":"10.1001\/jama.2016.1933"},{"key":"ref65","doi-asserted-by":"publisher","unstructured":"Li J, Chen L, Guo F, Han X. The Effects of GABAergic System under Cerebral Ischemia: Spotlight on Cognitive Function. Neural Plasticity. 2020; 2020: 8856722.","DOI":"10.1155\/2020\/8856722"},{"key":"ref66","doi-asserted-by":"publisher","unstructured":"Hagberg G, Ihle-Hansen H, Sandset EC, Jacobsen D, Wimmer H, Ihle-Hansen H. Long Term Cognitive Function After Cardiac Arrest: A Mini-Review. Frontiers in Aging Neuroscience. 2022; 14: 885226.","DOI":"10.3389\/fnagi.2022.885226"},{"key":"ref67","doi-asserted-by":"publisher","unstructured":"Nolan JP, Sandroni C, B\u00f6ttiger BW, Cariou A, Cronberg T, Friberg H, et al. European Resuscitation Council and European Society of Intensive Care Medicine Guidelines 2021: Post-resuscitation care. Resuscitation. 2021; 161: 220\u2013269.","DOI":"10.1016\/j.resuscitation.2021.02.012"},{"key":"ref68","doi-asserted-by":"publisher","unstructured":"Steinbusch CVM, van Heugten CM, Rasquin SMC, Verbunt JA, Moulaert VRM. Cognitive impairments and subjective cognitive complaints after survival of cardiac arrest: A prospective longitudinal cohort study. Resuscitation. 2017; 120: 132\u2013137.","DOI":"10.1016\/j.resuscitation.2017.08.007"}],"container-title":["Alpha Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/AP\/27\/2\/10.31083\/AP45138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T10:43:32Z","timestamp":1777459412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/AP\/27\/2\/10.31083\/AP45138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026]]}},"alternative-id":["S2757-8038(26)02569-0"],"URL":"https:\/\/doi.org\/10.31083\/ap45138","relation":{},"ISSN":["2757-8038"],"issn-type":[{"value":"2757-8038","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,8]]},"article-number":"45138"}}